Research ArticleArticle
Expert Consensus on a Set of Outcomes to Assess the Effectiveness of Biologic Treatment in Psoriatic Arthritis: The MERECES Study
Juan D. Cañete, Joan M. Nolla, Ruben Queiro, Miguel J. Rodríguez, Miguel Ruiz and Luis Lizán for the MERECES Working Group
The Journal of Rheumatology February 2020, jrheum.191056; DOI: https://doi.org/10.3899/jrheum.191056
Juan D. Cañete
The project was supported by UCB Pharma. LL works for an independent research organization (Outcomes’10, S.L.) that has received fees for its contribution to the development and coordination of the project and to the writing of this manuscript. J.D. Cañete, MD, PhD, Arthritis Unit, Rheumatology Department, Hospital Clínic and IDIBAPS, Barcelona; J.M. Nolla, MD, PhD, Department of Rheumatology, Hospital Universitario de Bellvitge IDIBELL, L’Hospitalet de Llobregat, Barcelona; R. Queiro, MD, PhD, Department of Rheumatology, Hospital Universitario Central de Asturias, Oviedo; M.J. Rodríguez, MD, Management Unit, Hospital Universitario de Cabueñes, Gijón; M. Ruiz, PhD, Department of Social Psychology and Methodology, Facultad de Psicología, Universidad Autónoma de Madrid, Madrid; L. Lizán, MD, PhD, Outcomes’10 and Universidad Jaime I, Castellón, Spain. Address correspondence to Dr. J.D. Cañete, Arthritis Unit, Rheumatology Dept., Hospital Clinic, Villarroel 170, 08036 Barcelona, Spain. Email: jcanete@clinic.cat. Accepted for publication January 16, 2020.
Joan M. Nolla
The project was supported by UCB Pharma. LL works for an independent research organization (Outcomes’10, S.L.) that has received fees for its contribution to the development and coordination of the project and to the writing of this manuscript. J.D. Cañete, MD, PhD, Arthritis Unit, Rheumatology Department, Hospital Clínic and IDIBAPS, Barcelona; J.M. Nolla, MD, PhD, Department of Rheumatology, Hospital Universitario de Bellvitge IDIBELL, L’Hospitalet de Llobregat, Barcelona; R. Queiro, MD, PhD, Department of Rheumatology, Hospital Universitario Central de Asturias, Oviedo; M.J. Rodríguez, MD, Management Unit, Hospital Universitario de Cabueñes, Gijón; M. Ruiz, PhD, Department of Social Psychology and Methodology, Facultad de Psicología, Universidad Autónoma de Madrid, Madrid; L. Lizán, MD, PhD, Outcomes’10 and Universidad Jaime I, Castellón, Spain. Address correspondence to Dr. J.D. Cañete, Arthritis Unit, Rheumatology Dept., Hospital Clinic, Villarroel 170, 08036 Barcelona, Spain. Email: jcanete@clinic.cat. Accepted for publication January 16, 2020.
Ruben Queiro
The project was supported by UCB Pharma. LL works for an independent research organization (Outcomes’10, S.L.) that has received fees for its contribution to the development and coordination of the project and to the writing of this manuscript. J.D. Cañete, MD, PhD, Arthritis Unit, Rheumatology Department, Hospital Clínic and IDIBAPS, Barcelona; J.M. Nolla, MD, PhD, Department of Rheumatology, Hospital Universitario de Bellvitge IDIBELL, L’Hospitalet de Llobregat, Barcelona; R. Queiro, MD, PhD, Department of Rheumatology, Hospital Universitario Central de Asturias, Oviedo; M.J. Rodríguez, MD, Management Unit, Hospital Universitario de Cabueñes, Gijón; M. Ruiz, PhD, Department of Social Psychology and Methodology, Facultad de Psicología, Universidad Autónoma de Madrid, Madrid; L. Lizán, MD, PhD, Outcomes’10 and Universidad Jaime I, Castellón, Spain. Address correspondence to Dr. J.D. Cañete, Arthritis Unit, Rheumatology Dept., Hospital Clinic, Villarroel 170, 08036 Barcelona, Spain. Email: jcanete@clinic.cat. Accepted for publication January 16, 2020.
Miguel J. Rodríguez
The project was supported by UCB Pharma. LL works for an independent research organization (Outcomes’10, S.L.) that has received fees for its contribution to the development and coordination of the project and to the writing of this manuscript. J.D. Cañete, MD, PhD, Arthritis Unit, Rheumatology Department, Hospital Clínic and IDIBAPS, Barcelona; J.M. Nolla, MD, PhD, Department of Rheumatology, Hospital Universitario de Bellvitge IDIBELL, L’Hospitalet de Llobregat, Barcelona; R. Queiro, MD, PhD, Department of Rheumatology, Hospital Universitario Central de Asturias, Oviedo; M.J. Rodríguez, MD, Management Unit, Hospital Universitario de Cabueñes, Gijón; M. Ruiz, PhD, Department of Social Psychology and Methodology, Facultad de Psicología, Universidad Autónoma de Madrid, Madrid; L. Lizán, MD, PhD, Outcomes’10 and Universidad Jaime I, Castellón, Spain. Address correspondence to Dr. J.D. Cañete, Arthritis Unit, Rheumatology Dept., Hospital Clinic, Villarroel 170, 08036 Barcelona, Spain. Email: jcanete@clinic.cat. Accepted for publication January 16, 2020.
Miguel Ruiz
The project was supported by UCB Pharma. LL works for an independent research organization (Outcomes’10, S.L.) that has received fees for its contribution to the development and coordination of the project and to the writing of this manuscript. J.D. Cañete, MD, PhD, Arthritis Unit, Rheumatology Department, Hospital Clínic and IDIBAPS, Barcelona; J.M. Nolla, MD, PhD, Department of Rheumatology, Hospital Universitario de Bellvitge IDIBELL, L’Hospitalet de Llobregat, Barcelona; R. Queiro, MD, PhD, Department of Rheumatology, Hospital Universitario Central de Asturias, Oviedo; M.J. Rodríguez, MD, Management Unit, Hospital Universitario de Cabueñes, Gijón; M. Ruiz, PhD, Department of Social Psychology and Methodology, Facultad de Psicología, Universidad Autónoma de Madrid, Madrid; L. Lizán, MD, PhD, Outcomes’10 and Universidad Jaime I, Castellón, Spain. Address correspondence to Dr. J.D. Cañete, Arthritis Unit, Rheumatology Dept., Hospital Clinic, Villarroel 170, 08036 Barcelona, Spain. Email: jcanete@clinic.cat. Accepted for publication January 16, 2020.
Luis Lizán
The project was supported by UCB Pharma. LL works for an independent research organization (Outcomes’10, S.L.) that has received fees for its contribution to the development and coordination of the project and to the writing of this manuscript. J.D. Cañete, MD, PhD, Arthritis Unit, Rheumatology Department, Hospital Clínic and IDIBAPS, Barcelona; J.M. Nolla, MD, PhD, Department of Rheumatology, Hospital Universitario de Bellvitge IDIBELL, L’Hospitalet de Llobregat, Barcelona; R. Queiro, MD, PhD, Department of Rheumatology, Hospital Universitario Central de Asturias, Oviedo; M.J. Rodríguez, MD, Management Unit, Hospital Universitario de Cabueñes, Gijón; M. Ruiz, PhD, Department of Social Psychology and Methodology, Facultad de Psicología, Universidad Autónoma de Madrid, Madrid; L. Lizán, MD, PhD, Outcomes’10 and Universidad Jaime I, Castellón, Spain. Address correspondence to Dr. J.D. Cañete, Arthritis Unit, Rheumatology Dept., Hospital Clinic, Villarroel 170, 08036 Barcelona, Spain. Email: jcanete@clinic.cat. Accepted for publication January 16, 2020.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Expert Consensus on a Set of Outcomes to Assess the Effectiveness of Biologic Treatment in Psoriatic Arthritis: The MERECES Study
Juan D. Cañete, Joan M. Nolla, Ruben Queiro, Miguel J. Rodríguez, Miguel Ruiz, Luis Lizán
The Journal of Rheumatology Feb 2020, jrheum.191056; DOI: 10.3899/jrheum.191056